Could time limits on opioid prescriptions reduce misuse?

Hundreds of thousands of surgical and dental opioid prescriptions are filled a month or more after writing, but one state’s law helped reduce this “delayed dispensing”.

11:13 AM

Author | Kara Gavin

prescription pad

Most people who get a prescription for opioid painkillers to ease the pain of an operation or dental procedure fill it right away. But a study shows that some fill these prescriptions more than a month later – long after the acute pain from their care should have subsided.

In 2019, 1% of opioid prescriptions from dentists and surgeons were filled more than 30 days after writing, according to the study in JAMA Network Open by a team from the University of Michigan. While low, that percentage would translate to more than 260,000 opioid prescriptions per year if it generalized to all surgical and opioid prescriptions in the United States.

"Our findings suggest that some patients use opioids from surgeons and dentists for a reason or during a time frame other than intended by the prescriber," said lead author Kao-Ping Chua, M.D., Ph.D, a U-M pediatrician and member of the Susan B. Meister Child Health Evaluation and Research (CHEAR) Center and the U-M Institute for Healthcare Policy and Innovation. "These are both forms of prescription opioid misuse, which in turn is a strong risk factor for opioid overdose."

The study authors note that state and federal laws regulating the expiration periods for controlled substance prescriptions may be partly to blame.

In 2019, 18 states allowed prescriptions for Schedule II opioids and other controlled substances – those with the highest risk of being diverted for misuse – to be filled up to 6 months after writing. Another eight states allowed these drugs to be dispensed up to 1 year after the prescription.

"It's perplexing that states would allow controlled substance prescriptions to be filled so long after they are written," said Chua. He notes that tightening state laws could be a straightforward way to prevent or reduce misuse associated with delayed dispensing of opioids.

As evidence, the study examined the effects of a law in Minnesota, which in July 2019 prohibited opioid dispensing more than 30 days after writing. After implementation, delayed dispensing dropped rapidly compared to other states.  

The authors note that an across-the-board rule limiting the time window for filling opioid prescriptions might inadvertently harm patients who take the drugs for chronic pain. Instead, they say, policymakers could implement laws that limit this time window only when opioids are written for acute pain.

The authors also note that prescribers can reduce delayed dispensing by including instructions on the prescription not to dispense opioids after a certain time frame.

In addition to Chua, the study's authors include Romesh Nalliah from the U-M School of Dentistry, Michael Smith from the U-M School of Pharmacy, research assistant Shreya Bahl, and Jennifer Waljee and Chad Brummett, both of whom are co-directors of the Michigan Opioid Prescribing and Engagement Network.

OPEN, as it's known, offers evidence-based opioid prescribing guidelines and educational materials for opioids for acute pain, and works to increase safe disposal options.

Paper cited: "Estimation of the Prevalence of Delayed Dispensing Among Opioid Prescriptions From US Surgeons and Dentists," JAMA Netw Open. DOI: 10.1001/jamanetworkopen.2022.14311


More Articles About: Lab Notes Medication Guidelines Health Care Delivery, Policy and Economics Acute Pain Pharmacy
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories woman holding face looking stressed on white couch in white shirt dark blue pants
Health Lab
Health costs top older adults’ list of concerns for people their age, poll finds
People over 50 of all backgrounds say they’re most concerned about various kinds of health costs affecting people their age, including insurance, prescriptions, medical care, dental care and home or longterm care.
Health care provider with stethoscope holds patient's hand
Health Lab
Opinion: Hospice care for those with dementia falls far short of meeting people’s needs at the end of life
An end-of-life care specialist discusses the shortfalls of hospice care coverage for people with dementia, using the experience of former President Jimmy Carter and former First Lady Rosalynn Carter as examples.
Illustration of doctor pictured outside a pill bottle that houses a bent-over figure with pills lying on the ground
Health Lab
It’s easier now to treat opioid addiction with medication -- but use has changed little
Buprenorphine prescribing for opioid addiction used to require a special waiver from the federal government, but a new study shows what happened in the first year after that requirement was lifted.
Pill capsule pushing through a paper with amoxicillin printed on it.
Health Lab
Rise seen in use of antibiotics for conditions they can’t treat – including COVID-19
Overuse of antibiotics can lead bacteria to evolve antimicrobial resistance, but Americans are still receiving the drugs for many conditions that they can’t treat.
marijuana leaf drawing blue lab note yellow badge upper left corner
Health Lab
Data shows medical marijuana use decreased in states where recreational use became legal 
Data on medical cannabis use found that enrollment in medical cannabis programs increased overall between 2016 and 2022, but enrollment in states where nonmedical use of cannabis became legal saw a decrease in enrollment
Illustration of prescription bottle with a refill notice
Health Lab
In drive to deprescribe, heartburn drug study teaches key lessons
An effort to reduce use of PPI heartburn drugs in veterans because of overuse, cost and potential risks succeeded, but provides lessons about deprescribing efforts.